GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (BOM:506197) » Definitions » Other Long Term Assets

Bliss GVS Pharma (BOM:506197) Other Long Term Assets : ₹367 Mil (As of Mar. 2025)


View and export this data going back to 1991. Start your Free Trial

What is Bliss GVS Pharma Other Long Term Assets?

Bliss GVS Pharma's other long-term assets for the quarter that ended in Mar. 2025 was ₹367 Mil.

Bliss GVS Pharma's quarterly other long-term assets declined from Sep. 2024 (₹439 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹367 Mil).

Bliss GVS Pharma's annual other long-term assets declined from Mar. 2023 (₹628 Mil) to Mar. 2024 (₹125 Mil) but then increased from Mar. 2024 (₹125 Mil) to Mar. 2025 (₹367 Mil).

Bliss GVS Pharma Other Long Term Assets Historical Data

The historical data trend for Bliss GVS Pharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma Other Long Term Assets Chart

Bliss GVS Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 754.73 289.70 628.07 125.01 367.11

Bliss GVS Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 125.01 - 439.26 - 367.11

Bliss GVS Pharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Bliss GVS Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (BOM:506197) » Definitions » Other Long Term Assets
Comparable Companies
BOM:539872 BOM:524669 NSE:BETA BOM:524470 BOM:507789 BOM:543329 BOM:590006 BOM:543389 BOM:530199 BOM:531633 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
BLISSGVS:India
Address
Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072
Website
https://www.blissgvs.com
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from exports.

Bliss GVS Pharma Headlines

No Headlines